Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Dementia and APOA1[original query] |
|---|
| An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 2009 Feb 15 (2): 174-9. Koutsis G, Panas M, Giogkaraki E, Karadima G, Sfagos C, Vassilopoulos |
| Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly. Journal of Alzheimer's disease : JAD 2016 12 56 (2): 687-697. Slot Rosalinde E R, Van Harten Argonde C, Kester Maartje I, Jongbloed Wesley, Bouwman Femke H, Teunissen Charlotte E, Scheltens Philip, Veerhuis Robert, van der Flier Wiesje |
| Apolipoprotein A1 in Cerebrospinal Fluid Is Insufficient to Distinguish Alzheimer's Disease from Other Dementias in a Naturalistic, Clinical Setting. Journal of Alzheimer's disease reports 2020 Feb 4 (1): 15-19. Stoye Nicolai Maximilian, Jung Patrick, Guilherme Malena Dos Santos, Lotz Johannes, Fellgiebel Andreas, Endres Kristi |
- Page last reviewed:Feb 1, 2024
- Content source: